Načítá se...
The Costs of Industry-Sponsored Drug Trials in Canada
OBJECTIVE: The objective of this study was to estimate the provincial and nationwide costs of industry-sponsored drug clinical trials (CTs) in Canada. METHODS: We used the Aggregate Analysis of ClinicalTrials.gov (AACT) database, and included all industry-sponsored drug CTs that were conducted in Ca...
Uloženo v:
| Vydáno v: | Pharmacoecon Open |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer International Publishing
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7248139/ https://ncbi.nlm.nih.gov/pubmed/31292934 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s41669-019-0161-0 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|